TY - JOUR
T1 - Developmental Neurotoxicity (DNT)
T2 - A Call for Implementation of New Approach Methodologies for Regulatory Purposes: Summary of the 5th International Conference on DNT Testing
AU - Celardo, Ivana
AU - Aschner, Michael
AU - Ashton, Randolph S.
AU - Carstens, Kelly E.
AU - Cediel-Ulloa, Andrea
AU - Cöllen, Eike
AU - Crofton, Kevin M.
AU - Debad, Susan J.
AU - Dreser, Nadine
AU - Fitzpatrick, Suzanne
AU - Fritsche, Ellen
AU - Gutsfeld, Sebastian
AU - Hardy, Barry
AU - Hartung, Thomas
AU - Hessel, Ellen
AU - Heusinkveld, Harm
AU - Hogberg, Helena T.
AU - Hsieh, Jui Hua
AU - Kanda, Yasunari
AU - Knight, Gavin T.
AU - Knudsen, Thomas
AU - Koch, Katharina
AU - Kuchovska, Eliska
AU - Mangas, Iris
AU - Marty, M. Sue
AU - Melching-Kollmuss, Stephanie
AU - Müller, Iris
AU - Müller, Patrick
AU - Myhre, Oddvar
AU - Paparella, Martin
AU - Pitzer, Emily
AU - Bal-Price, Anna
AU - Sachana, Magdalini
AU - Schlüppmann, Kevin
AU - Shafer, Timothy J.
AU - Schäfer, Jasmin
AU - Smirnova, Lena
AU - Tal, Tamara
AU - Tanaskov, Yaroslav
AU - Tangianu, Silvia
AU - Testa, Giuseppe
AU - Ückert, Anna Katharina
AU - Whelan, Maurice
AU - Leist, Marcel
N1 - Publisher Copyright:
© The Authors, 2025.
PY - 2025
Y1 - 2025
N2 - The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the application and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field’s embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.
AB - The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the application and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field’s embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.
UR - https://www.scopus.com/pages/publications/105003113388
UR - https://www.scopus.com/pages/publications/105003113388#tab=citedBy
U2 - 10.14573/altex.2503191
DO - 10.14573/altex.2503191
M3 - Article
C2 - 40235170
AN - SCOPUS:105003113388
SN - 1868-596X
VL - 42
SP - 323
EP - 349
JO - Altex
JF - Altex
IS - 2
ER -